Figure 5
Figure 5. Kaplan-Meier curves for time to first treatment and overall survival defined by the combination of Mcl-1/Bax ratios and VH gene mutation status, CD38 expression, and ZAP-70 expression (whole cohort). Mcl-1/Bax ratios in combination with VH gene mutation status (A,B), CD38 expression (C,D), and ZAP-70 expression (E,F) increased the prognostic power of each parameter in defining time to first treatment. However, this was not the case for overall survival.

Kaplan-Meier curves for time to first treatment and overall survival defined by the combination of Mcl-1/Bax ratios and VH gene mutation status, CD38 expression, and ZAP-70 expression (whole cohort). Mcl-1/Bax ratios in combination with VH gene mutation status (A,B), CD38 expression (C,D), and ZAP-70 expression (E,F) increased the prognostic power of each parameter in defining time to first treatment. However, this was not the case for overall survival.

Close Modal

or Create an Account

Close Modal
Close Modal